Allergia-, Iho- ja Astmaliitto ry

What Allergia-, Iho- ja Astmaliitto ry does

Allergia-, Iho- ja Astmaliitto ry (the Finnish Allergy, Skin and Asthma Federation) is a Helsinki-based, registered Finnish non-profit association (yhdistys) founded in 1969 that serves as Finland's national patient advocacy federation for people affected by allergies, asthma, and skin conditions, including severe burn injuries and rare skin diseases. The organization operates a federated model comprising a small central staff of seven, supported by a national network of regional member associations, and delivers a multi-channel service platform covering the Allergiatunnus (Allergy Label) product certification mark, online and in-person courses (Verkkokurssit and Kurssit), expert consultation services (Neuvonta), a digital materials repository and magazine (Materiaalipankki, Allergia, Iho & Astma -lehti), web lectures (Verkkoluennot), peer support programs (Vertaistuki), and a mobile membership card (Mobiilijäsenkortti), with content available in Finnish, Swedish, and English. The federation's business model is non-commercial at the point of service: courses are provided free to participants, with revenue derived from individual and association membership fees, public-sector and non-profit grants, donations, enterprise cooperation partnerships with pharmaceutical and distribution firms (including AbbVie, ALK-Abelló Nordic, GSK, Novartis Finland, Orion Pharma, Oriola, Sanofi, and UCB Pharma Finland), and licensing income from the Allergiatunnus certification mark. Distribution is executed through the Helsinki headquarters, the regional member association network, an in-house online course platform, YouTube-hosted lectures, and the parliamentary Allergy and Asthma Network (Eduskunnan allergia- ja astmaverkosto) for advocacy. In 2025, the federation organized 36 courses serving 515 participants with 894 applications, and is operating under a published Strategy 2026-2030 alongside the Ikääntyvän astmaatikon liikuntapolku project (2025-2027).

Name

Allergia-, Iho- ja Astmaliitto ry

Legal name

Allergia-, Iho- ja Astmaliitto ry

Website

https://allergia.fi

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Allergia-, Iho- ja Astmaliitto ry is Finland's national non-profit patient federation (founded 1969, 7 staff, Helsinki) that provides courses, counseling, peer support, advocacy, and the Allergiatunnus product label for people with allergies, asthma, and skin conditions.

Ownership category

akta.pro rank

Product category

Patient Advocacy and Chronic Disease Support

NAICS

Other Similar Organizations (except Business, Professional, Labor, and Political Organizations) (813990), Other Individual and Family Services (624190), Child and Youth Services (624110)

SIC

Services-Health Services (8000)

akta.pro primary industry

Allergy & Immunology Clinics (HLAKAAAA)

akta.pro secondary industries

Pediatric Allergy & Immunology (HLAKAAAB), Food Allergy Evaluation & Management (HLAKAAAD), Asthma & Allergy-Related Pulmonary Care (HLAKANAD), “Free-From” & Allergen-Free Claim Substantiation (e.g., gluten-free, peanut-free) (AFALAHAD)

Keywords

• Patient advocacy services
• Allergy support
• Asthma education
• Skin disease support
• Peer support programs

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Pricing tiers

Distribution channels4 records

Marketing channels6 records

Core offering

Allergia-, Iho- ja Astmaliitto ry is a Finnish non-profit patient advocacy organization that provides information, counseling, courses, peer support, and advocacy services for people with allergies, asthma, and skin diseases. Its core offerings include the Allergiatunnus (Allergy Label) certification mark for fragrance-free products, online and in-person courses, expert consultation, a digital materials bank, web lectures, and peer support programs including supported holidays.

Product overview

Allergia-, Iho- ja Astmaliitto ry is a Finnish patient advocacy organization providing information, education, and support services for people with allergies, asthma, and skin diseases. The organization operates a multi-channel service platform consisting of: the Allergiatunnus (Allergy Label) product certification program; Verkkokurssit online courses; in-person Kurssit courses; Neuvonta consultation services; Materiaalipankki materials repository; Verkkoluennot web lectures; and Vertaistuki peer support programs. The organization also provides member benefits including a Mobiilijäsenkortti mobile card, and publishes the Allergia, Iho & Astma magazine. Services are available in Finnish, Swedish, and English, serving both patients and healthcare professionals.

Differentiator

Problem solved

Functional benefit

Products and services

• Allergiatunnus (Allergy Label) A certification mark granted to products that are fragrance-free and suitable for people with allergies, asthma, and skin conditions, meeting specific criteria for being free from fragrances and common allergens. Licensed for use by product manufacturers and available to consumers as a trusted identification aid.
• Verkkokurssit (Online Courses) Self-paced online courses on asthma, atopic dermatitis, alopecia, food allergies, anaphylaxis, and relaxation techniques, delivered through the association's online course platform with video lectures, exercises, and peer discussions, free for participants.
• Kurssit (In-Person Courses) Residential and in-person courses for adults, families with children, and youth on asthma, atopic dermatitis, alopecia, rare skin diseases, and related topics, including exercise and wellness programs held at venues such as Pajulahden kampus.
• Neuvonta (Consultation Services) Expert phone and email consultation on allergies, asthma, and skin diseases for members, including the 'Ask an Expert' column with Q&A on allergy-related topics.
• Materiaalipankki (Material Bank) Digital repository of guides, printable materials, and the Allergia, Iho & Astma magazine for members and professionals, including campaign materials, image bank, and exercise materials.
• Verkkoluennot (Web Lectures) Recorded expert lectures on topics including anaphylaxis, asthma, atopic dermatitis, skin conditions, food allergies, and pollen allergy, published through the association's YouTube channel.
• Vertaistuki (Peer Support) Peer support program offering supported holidays, peer meetings, online peer support, and personal stories from people living with allergies, asthma, and skin conditions.
• Mobiilijäsenkortti (Mobile Member Card) Digital membership card accessible via mobile device for member identification and benefits verification within the federation.

Quantifiable outcome

• 36 courses organized in 2025 with 515 participants and 894 applications received
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered minor and core.

• AbbvieminorGTM or Marketing PartnerPharmaceutical company listed as a cooperation partner in 2026. AbbVie focuses on immunology, oncology, neuroscience, and other areas.
• ALK-Abelló NordicminorGTM or Marketing PartnerPharmaceutical company specializing in allergy treatments, listed as a cooperation partner in 2026.
• GSK (GlaxoSmithKline)minorGTM or Marketing PartnerGlobal pharmaceutical company listed as a cooperation partner in 2026. GSK focuses on vaccines, pharmaceuticals, and consumer healthcare.
• Novartis Finland OyminorGTM or Marketing PartnerPharmaceutical company listed as a cooperation partner in 2026. Novartis focuses on innovative medicines.
• Orion PharmaminorGTM or Marketing PartnerFinnish pharmaceutical company listed as a cooperation partner in 2026. Orion develops and manufactures pharmaceuticals.
• OriolaminorGTM or Marketing PartnerPharmaceutical wholesale and distribution company listed as a cooperation partner in 2026.
• SanofiminorGTM or Marketing PartnerGlobal pharmaceutical company listed as a cooperation partner in 2026. Sanofi focuses on pharmaceuticals and vaccines.
• UCB Pharma FinlandminorGTM or Marketing PartnerPharmaceutical company listed as a cooperation partner in 2026. UCB focuses on immunology and neurology.
• Päijät-Hämeen Allergia-, Atopia- ja AstmayhdistyscoreStrategic or Co-development PartnerRegional member association that co-organizes courses with the national federation, such as the Kasvojen iho (Facial Skin) course on September 5, 2026 at Pajulahden kampus.

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Asthma + Lung UK: UK-based charity offering advice, courses, peer support, and advocacy for people with asthma and allergies. Strong comparable on information/counseling delivery and pharma-supported funding model.
• Allergy UK: UK national charity dedicated to allergy support, helpline advice, product endorsement, and resources for patients and healthcare professionals. Directly comparable mission and service design to AIA.
• Norges Astma- og Allergiforbund (NAAF): Norwegian asthma and allergy patient association offering information, counseling, peer support, and local chapters — closely mirroring AIA's Finnish federation structure and service mix.
• Asthma och Allergiförbundet (Swedish Asthma and Allergy Association): Sweden's national patient advocacy organization for asthma and allergies, providing courses, peer support, and information. Most direct comparable given Nordic neighbor, similar disease scope (asthma/allergy), and federation model.

Emerging players

• National Eczema Association (NEA): US non-profit for atopic dermatitis/eczema patients offering education, support, and advocacy. Directly comparable to AIA's atopic dermatitis course and skin-disease programming.
• Food Allergy Research & Education (FARE): US-focused food allergy patient advocacy and research organization. Comparable as a single-disease advocacy group with education, peer support, and pharma partnerships overlapping AIA's food allergy programs.

Others

• European Lung Foundation: European-level organization translating lung-research findings (including asthma) for patients and policymakers. Comparable as an adjacent ecosystem participant rather than a direct competitor.

Broad incumbents

• American Lung Association: Large US non-profit providing lung-health (including asthma) information, courses, advocacy, and research funding. Comparable on advocacy, education, and partnership-driven funding, though at much larger scale.
• European Federation of Allergy and Airways Diseases Patients' Associations (EFA): Pan-European umbrella federation for national allergy/asthma patient groups. Comparable as the supra-national aggregator AIA could either partner with or compete against for pharma sponsorship.

Regional players

• Canadian Lung Association: Canada's national lung-health charity (including asthma). Comparable operating model and disease scope, though operating in a different geography.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/allergiajaastma
• LinkedInlinkedin.com/company/allergia-iho-ja-astmaliitto-ry

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allergia-, Iho- ja Astmaliitto ry